Log In
Print
BCIQ
Print
Print this Print this
 

FX06MRI

  Manage Alerts
Collapse Summary General Information
Company Fibrex Medical Inc.
DescriptionAnti-inflammatory peptide that inhibits the binding of fibrin E1 fragment to vascular endothelial (VE) cadherin
Molecular Target Fibrin
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationIschemia / reperfusion injury
Indication DetailsPrevent ischemia/reperfusion injury following revascularization for acute myocardial infarction (AMI); Treat ischemia/reperfusion injury after revascularisation therapy for myocardial infarction (MI)
Regulatory Designation

Partner

Mallinckrodt plc


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today